跳至主要内容
临床试验/SLCTR/2021/005
SLCTR/2021/005尚未招募2 期

Assessment of the efficacy of the indigenous polyherbal drug Desandun Kalka” against SARS-CoV- 2 infection

Department of Ayurveda0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • * Age > 18 years
  • Both male and female
  • * PCR positive for SARS-CoV- 2
  • * The patient clinically assessed and categorized according to the tool published by Min. of Health, Sri Lanka, Provisional Guidelines for Clinical Management of COVID-19, (March 2020)” as patients with mild symptoms of SARS COVID-19 infection and defined as below:
  • - Respiratory Rate (RR/min) 12 – 20
  • - Heart Rate (HR/min) < 100
  • - O2 Saturation – on room air (% by Pulse Oxymeter) > 94

排除标准

  • * Pregnant and breast feeding mothers
  • * Those with severe and moderate illness (COVID 19)
  • * Chronic Liver Cell Disease (CLCD),
  • * Chronic Kidney Disease (CKD)
  • * Those who are unable to take the drug orally

研究者

发起方
Department of Ayurveda

相似试验